The dermatology hospitalist: Creating value by rapid clinical pathologic correlation in a patient-centered care model

International Journal of Dermatology

Volumn 51, Issue 12, 2012, Pages 1461-1466

  El Azhary, Rokea ^a   Weenig, Roger H ^a   Gibson, Lawrence E ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIBIOTIC AGENT; CEFEPIME; CORTICOSTEROID; DAPSONE; IMMUNOGLOBULIN; METHOTREXATE; METHYLPREDNISOLONE; PREDNISONE; TACROLIMUS; TRIAMCINOLONE; VANCOMYCIN;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CASE REPORT; CELLULITIS; CLINICAL EVALUATION; DERMATOLOGIST; DERMATOLOGY; DERMATOLOGY HOSPITALIST; FEMALE; HEALTH CARE PERSONNEL; HOSPITAL; HOSPITAL PATIENT; HOSPITAL PERSONNEL; HUMAN; HUMAN TISSUE; LEG ULCER; MALE; MEDICAL PRACTICE; MORBIDITY; MUCOR; MYCOSIS; PATIENT CARE; PATIENT SATISFACTION; POLYARTERITIS NODOSA; SKIN BIOPSY; SKIN DISEASE; STEVENS JOHNSON SYNDROME; THERAPY DELAY;

AGED, 80 AND OVER; CHILD; DERMATOLOGY; FEMALE; HAND DERMATOSES; HODGKIN DISEASE; HOSPITALISTS; HUMANS; LYMPHOMA; MALE; MIDDLE AGED; MODELS, ORGANIZATIONAL; PATHOLOGY, CLINICAL; PATIENT-CENTERED CARE; POLYARTERITIS NODOSA; SKIN DISEASES; SKIN NEOPLASMS; STEVENS-JOHNSON SYNDROME; YOUNG ADULT;

EID: 84869869935     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2011.05412.x     Document Type: Article

References (16)

1. El-Azhary RA. Hospital practice. In: Davis MDP, ed. Mayo Clinic Dermatology: The First Ninety Years. Rochester, MN: Mayo Foundation for Medical Education and Research, 2007: 95-102.
2. Wachter RM. An introduction to the hospitalist model. Ann Intern Med 1999; 130: 338-342.
3. Wachter RM, Goldman L. The hospitalist movement 5years later. JAMA 2002; 287: 487-494.
4. Freed DH. Hospitalists: evolution, evidence, and eventualities. Health Care Manag (Frederick) 2004; 23: 238-256.
5. Cammarata JF. The hospitalist: creating a patient-focused paradigm for a change. J Am Med Dir Assoc 2005; 6: 162-164.
6. Kirsner RS, Yang DG, Kerdel FA. Inpatient dermatology: the difficulties, the reality, and the future. Dermatol Clin 2000; 18: 383-390.
7. Kirsner RS, Hannon W, Agarwal A, Kerdel FA. The effect of health care delivery systems on admission to and treatment at an inpatient dermatology unit. Dermatol Clin 2000; 18: 391-395.
8. Kirsner RS, Yang DG, Kerdel FA. The changing status of inpatient dermatology at American academic dermatology programs. J Am Acad Dermatol 1999; 40: 755-757.
9. Callahan EF, Adal KA, Tomecki KJ. Cutaneous (non-HIV) infections. Dermatol Clin 2000; 18: 497-508.
10. Nahass GT. Inpatient dermatology consultation. Dermatol Clin 2000; 18: 533-542.
11. Ayyalaraju RS, Finlay AY, Dykes PJ, et al. Hospitalization for severe skin disease improves quality of life in the United Kingdom and the United States: a comparative study. J Am Acad Dermatol 2003; 49: 249-254.
12. Meves A, El-Azhary RA, Talwalkar JA, et al. Acute graft-versus-host disease after liver transplantation diagnosed by fluorescent in situ hybridization testing of skin biopsy specimens. J Am Acad Dermatol 2006; 55: 642-646.
13. Chavan R, El-Azhary R. Cutaneous graft-versus-host disease: rationales and treatment options. Dermatol Ther 2011; 24: 219-228.
14. Weenig RH, Sewell LD, Davis MD, et al. Calciphylaxis: natural history, risk factor analysis, and outcome. J Am Acad Dermatol 2007; 56: 569-579.
15. Sewell LD, Weenig RH, Davis MD, et al. Low-dose tissue plasminogen activator for calciphylaxis. Arch Dermatol 2004; 140: 1045-1048.
16. Weenig RH, Gibson LE, El-Azhary R. The role of the hospital dermatologist in the diagnosis and treatment of calciphylaxis and nephrogenic systemic fibrosis. Semin Cutan Med Surg 2007; 26: 163-167.